Today: December 13, 2018, 10:08 pm
  
Business

ObsEva SA to Participate in BMO Healthcare Conference December 12, 2018

PR-Inside.com: 2018-12-06 07:03:02


Geneva, Switzerland and Boston, MA – December 6, 2018 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman’s reproductive health and pregnancy, today announced that Company Management will be participating in the BMO Prescriptions for Success Healthcare Conference taking place December 12, 2018 in New York City. 

ObsEva will be presenting on December 12 at 2p.m. Eastern Time (ET).  A webcast of the presentation will be available in the “Investors” section of ObsEva’s website www.ObsEva.com.


About ObsEva

ObsEva is a clinical-stage biopharmaceutical company focused on the clinical development and commercialization of novel therapeutics for serious conditions that compromise a woman's reproductive health and pregnancy. Through strategic in-licensing and disciplined drug development, ObsEva has established a late-stage clinical pipeline with development programs focused on treating endometriosis, uterine fibroids, preterm labor and improving IVF outcomes. ObsEva is listed on the NASDAQ Global Select Market and is trading under the ticker symbol "OBSV" and on the SIX Swiss Exchange where it is trading under the ticker symbol “OBSN”. For more information, please visit www.ObsEva.com.


For further information, please contact:


Media Contact Switzerland and Europe:
Christophe Lamps
Dynamics Group
cla@dynamicsgroup.ch
+41 22 308 6220 Office
+41 79 476 26 87 Mobile

Media Contact U.S.:
Marion Janic
RooneyPartners LLC
mjanic@rooneyco.com
+1 212 223 4017 Office
+1 646 537 5649 Mobile

CEO Office Contact:
Shauna Dillon
Shauna.dillon@obseva.ch
+41 22 552 1550

Investor Contact:
Mario Corso
Senior Director, Investor Relations
mario.corso@obseva.com
+1 857 972 9347 Office
+1 781 366 5726 Mobile



Attachment




# 590 Words
Related Articles
More From The Author
Notice regarding to proposal by exercising right [..]
AB Klaipėdos nafta, legal entity code 110648893, registered address Buriu str. 19, Klaipeda (hereinafter – the Company), by [..]
Toshiba Adds New 12TB and 14TB Helium-Sealed [..]
Toshiba Electronic Devices & Storage Corporation : This press release features multimedia. View the full release here. Toshiba: [..]
Tenaris informs the market on prosecutors’ request [..]
LUXEMBOURG, Dec. 05, 2018 (GLOBE NEWSWIRE) -- Tenaris S.A. (NYSE, Buenos Aires and Mexico: TS and MTA Italy: TEN) has [..]
Constellation Brands to Report Third Quarter Fiscal [..]
VICTOR, N.Y., Dec. 05, 2018 (GLOBE NEWSWIRE) -- Constellation Brands, Inc. (NYSE: STZ and STZ.B), a leading beverage alcohol company, [..]
AM Best Assigns Credit Ratings to AVLA [..]
AM Best has assigned a Financial Strength Rating of B++ (Good) and a Long-Term Issuer Credit Rating of “bbb” to [..]
 
More From Business
Learn about Dishonest Companies and Specialist on [..]
12 December 2018 – Beware.org provides the most favorable conditions for average consumers to publish the alerts and warnings about [..]
Brands Reviews Offers the Best Quality Reviews
12 December 2018 – Brands Reviews is offering the largest collection of reliable and trusted qqtube review and subpals review [..]
509 Electric Is the Best Residential Electrical [..]
Yakima, USA – 12 December 2018 – 509 Electric is the best Yakima Electrical Contractor ready to offer top quality [..]
Cross Talks Awarded $5K Grant from the [..]
The Penn State Brandywine Boost, a program of the Invent Penn State initiative, has selected Delaware State Chamber Member, Soraya [..]
Huber Needles: Market is likely to register [..]
This Market Study provides key insights and forecast on the global Huber needles market for the forecast period 2017-2024. The [..]

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.